Current evidence on the management of re-recurrent rectal cancer: a systematic review - Top-Institutions - MDSpire

Current evidence on the management of re-recurrent rectal cancer: a systematic review

By
Georgios Giannos
Panagiotis Theodoropoulos
Maximos Frountzas
Sheng Qiu
Maria Katsigeorgis
Sophia Y. Chen
Shahnawaz Rasheed
Paris Tekkis
Bashar Safar
Christos Kontovounisios
July 15, 2026

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Surgery
- Oncology
#2

Fondazione Policlinico Universitario “A. Gemelli” IRCCS

Rome, Italy
Key Differentiators
- Surgery
- Oncology
#3

Swedish Colorectal Cancer Registry

Stockholm, Sweden
Key Differentiators
- Surgery
- Oncology
#4

Fujian Medical University Union Hospital

Fuzhou, China
Key Differentiators
- Surgery
- Oncology
#5

Sant’Andrea University Hospital

Rome, Italy
Key Differentiators
- Surgery
- Oncology

Original Source(s)

Frontiers In Oncology

Current evidence on the management of re-recurrent rectal cancer: a systematic review

by Georgios Giannos, Panagiotis Theodoropoulos, Maximos Frountzas, Sheng Qiu, Maria Katsigeorgis, Sophia Y. Chen, Shahnawaz Rasheed, Paris Tekkis, Bashar Safar, Christos Kontovounisios
July 15, 2026

Related Content

Frontiers In Oncology

Evaluation of an interpretable deep-learning model for the automated plan review of intensity-modulated radiation therapy

by Yuhan Fan, Jiawen Shang, Ke Zhang, Zhihui Hu, Zhiqiang Liu, Hui Yan, Peng Huang
July 15, 2026

Frontiers In Oncology

Circular RNA circEVI5 functions as a miR-433 sponge to promote renal cell carcinoma progression via GBP2-mediated oncogenic signaling

by Yang Xiong, Jin Li, Zhi-Peng Tang, Xiao Xie, Yu Liang
July 15, 2026

Frontiers In Oncology

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients